A novel strategy for encapsulating poorly soluble drug into nanostructured lipid carriers for intravenous administration

References

• Lipinski CA. Poor aqueous solubility - an industry wide problem in drug discovery. Am Pharm Rev 2002;5:82–85.
   Google Scholar
• Wong J, Brugger A, Khare A, Chaubal M, Papadopoulos P, Rabinow B, Kipp J, Ning J. Suspensions for intravenous (IV) injection: A review of development, preclinical and clinical aspects. Adv Drug Deliver Rev 2008;60:939–954.
   PubMed Web of Science ®Google Scholar
• Brewster ME, Loftsson T. Cyclodextrins as pharmaceutical solubilizers. Adv Drug Deliver Rev 2007;59:645–666.
   PubMed Web of Science ®Google Scholar
• Blanco E, Kessinger CW, Sumer BD, Gao J. Multifunctional micellar nanomedicine for cancer therapy. Exp Biol Med 2009;234(2):123–131.
   Google Scholar
• Agarwal A, Lvov Y, Sawant R, Torchilin V. Stable nanocolloids of poorly soluble drugs with high drug content prepared using the combination of sonication and layer-by-layer technology. J Contr Rel 2008;128:255–260.
   PubMed Web of Science ®Google Scholar
• Wissing SA, Kayser O, Müller RH. Solid lipid nanoparticles for parenteral drug delivery. Adv Drug Deliver Rev 2004;56:1257–1272.
   PubMed Web of Science ®Google Scholar
• Lu W, He LC, Wang CH, Li YH, Zhang SQ. The use of solid lipid nanoparticles to target a lipophilic molecule to the liver after intravenous administration to mice. Int J Biol Macromol 2008;43(3):320–324.
   PubMedGoogle Scholar
• Kaur IP, Bhandari R, Bhandari S, Kakkar V. Potential of solid lipid nanoparticles in brain targeting. J Contr Rel 2008;127:97–109.
   PubMed Web of Science ®Google Scholar
• Jores K, Mehnert W, Drechsler M, Bunjes H, Johann C, Mäder K. Investigations on the structure of solid lipid nanoparticles (SLN) and oil-loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopy. J Contr Rel 2004;95:217–227.
   PubMed Web of Science ®Google Scholar
• Bialecka M. The Effect of bioflavonoids and lecithin on the course of experimental atherosclerosis in rabbits. Annu Acad Med Stein 1997;43:41–43.
   PubMedGoogle Scholar
• Bhardwaj U, Burgess DJ. Physicochemical properties of extruded and non-extruded liposomes containing the hydrophobic drug dexamethasone. Int J Pharma 2010;388:181–189.
   PubMed Web of Science ®Google Scholar
• China Pharmacopeial Convention. Chinese Pharmacopoeia. Beijing: China medical science and technology press, 2010;2:249.
   Google Scholar
• Kang LY. TLC identification for tabella prednisoni acetatis and tabella dexamethasoni acetates. Strait Pharma J 2005;17:62–63.
   Google Scholar
• Qin X, Yang Y, Fan TT, Gong T, Zhang XN, Huang Y. Preparation, characterization and in vivo evaluation of bergenin-phospholipid complex. Acta Pharmacol Sin 2010;31:127–136.
   Google Scholar
• Zhao XL, Yang CR, Yang KL, Li KX, Hu HY, Chen DW. Preparation and characterization of nanostructured lipid carriers loaded traditional Chinese medicine, zedoary turmeric oil. Drug Dev Ind Pharm. 2010;36(7):773–80.
   PubMedGoogle Scholar
• Boddu SHS, Jwala J, Vaishya R, Earla R, Karla PK, Pal D, Mitra AS. Novel Nanoparticulate Gel Formulations of Steroids for the Treatment of Macular Edema. J Ocul Pharmacol Th 2010;26:37–48.
   PubMed Web of Science ®Google Scholar
• Xiao YY, Song YM, Chen ZP, Ping QN. The preparation of silybin–phospholipid complex and the study on its pharmacokinetics in rats. Int J Pharm 2006;307:77–82.
   PubMed Web of Science ®Google Scholar
• Liang N, Shi K, Wang YS, Yu YW, Feng LL, Cui FD. Preparation and characterization of ferulic acid-phospholipid complex. J Shenyang Pharm University 2008;25:163–168.
   Google Scholar
• Maiti K, Mukherjee K, Gantait A, Saha BP, Mukherjee PK. Curcumin–phospholipid complex: Preparation, therapeutic evaluation and pharmacokinetic study in rats. Int J Pharm 2007;330:155–163.
   PubMed Web of Science ®Google Scholar
• Cui FD, Shi K, Zhang LQ, Tao AJ, Kawashima Y. Biodegradable nanoparticles loaded with insulin–phospholipid complex for oral delivery: Preparation, in vitro characterization and in vivo evaluation. J Contr Rel 2006;114:242–250.
   PubMed Web of Science ®Google Scholar
• Nekahi A, Dehghani K. Modeling the thermomechanical effects on baking behavior of low carbon steels using response surface methodology. Mater and Des 2010;31:3845–3851.
   Web of Science ®Google Scholar
• Gaete CG, Tsapis N, Besnard M, Bochot A, Fattal E. Encapsulation of dexamethasone into biodegradable polymeric nanoparticles. Int J Pharm 2007;331:153–159.
   PubMedGoogle Scholar
• Wei W, Shi SJ, Liu J, Sun X, Ren K, Zhao D, Zhang XN, Zhang ZR, Gong T. Lipid nanoparticles loaded with 10-hydroxycamptothecin–phospholipid complex developed for the treatment of hepatoma in clinical application. J Drug Target 2010;18:557–566.
   PubMed Web of Science ®Google Scholar
• Teeranachaideekul V, Boonme P, Souto EB, Müller RH, Junyaprasert VB. Influence of oil content on physicochemical properties and skin distribution of Nile red-loaded NLC. J Contr Rel 2008;128:134–141.
   PubMed Web of Science ®Google Scholar
• Jores K, Mehnert W, Mäder K. Physicochemical Investigations on Solid Lipid Nanoparticles and on Oil-Loaded Solid Lipid Nanoparticles: A Nuclear Magnetic Resonance and Electron Spin Resonance Study. Pharm Res 2003;20(8):1274–1283.
   PubMedGoogle Scholar
• Yang CR, Zhao XL, Hu HY, Li KX, Sun X, Li L, Cheng DW. Preparation, Optimization and Characteristic of Huperzine A Loaded Nanostructured Lipid Carriers. Chem Pharm Bull 2010;58(5):656–661.
   PubMedGoogle Scholar
• Doktorovova S, Souto EB. Nanostructured lipid carrier-based hydrogel formulations for drug delivery: A comprehensive review. Expet Opin Drug Deliv 2009;6(2):165–176.
   PubMedGoogle Scholar
• Lim SJ, Kim CK. Formulation parameters determining the physicochemical characteristics of solid lipid nanoparticles loaded with all-trans retinoic acid. Int J Pharm 2002;243:135–146.
   PubMed Web of Science ®Google Scholar